PTSM: Pharmaceutical Technology Sourcing and Management-05-07-2014

Kurt Lumsden, Director, eCDS Client Services at PAREXEL Informatics, discusses eClinical supply-chain management.

Janssen Pharmaceutical collaborates with Stop TB Partnership's Global Drug Facility to increase access to anti-TB compound.

New identifiers and tracking requirements aim to block illegitimate products.

Once an afterthought, packaging has now become an essential component of biopharmaceutical product development and marketing.

Bristol-Myers Squibb is named No. 1 on 2014 Best Corporate Citizens List for the third time in six years.

The Azzur Group and BioSPEQ merger will increase consulting services and project resources within the life-sciences industry.

Eli Lilly has developed the Lilly Medical Student Intern Program for future physicians.

How badly is Brazil's pharmaceutical market suffering from the global instability of emerging markets?

Changes are needed to maintain US biopharma innovation leadership.

Outsourcing activity remains strong and unlikely to abate, especially in more traditional areas.

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Novartis' eBook features images of meningococcal disease survivors from around the world.

Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.

Colorcon invests in significant expansion of its South Asia production facility.

Capsugel enters an agreement with Chiasma to increase manufacturing operations for octreotide, a treatment for acromegaly.

Sartorius Stedim Biotech's acquisition of AllPure Technologies will extends its portfolio for single-use bioprocessing.

Bristol-Myers Squibb and Samsung BioLogics expand their manufacturing agreement to cover biologic medicines.

UPM will commercially manufacture two ANDA products for Amerigen Pharmaceuticals.

BASF builds a new plant for specialty amines in Ludwigshafen, Germany.